SELTOLZA

Serial Number 90807080
Registration 6807011
700

Registration Progress

Application Filed
Jul 1, 2021
Under Examination
Approved for Publication
May 17, 2022
Published for Opposition
May 17, 2022
Registered
Aug 2, 2022

Trademark Image

SELTOLZA

Basic Information

Serial Number
90807080
Registration Number
6807011
Filing Date
July 1, 2021
Registration Date
August 2, 2022
Published for Opposition
May 17, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 2, 2022
Registration
Registered
Classes
005 044

Rights Holder

USWM CT, LLC

16
Address
4441 SPRINGDALE ROAD
LOUISVILLE, KY 40241

Ownership History

Adaptimmune Limited

Original Applicant
99
Abingdon, Oxford GB

Adaptimmune Limited

Owner at Publication
99
Abingdon, Oxford GB

Adaptimmune Limited

Original Registrant
99
Abingdon, Oxford GB

USWM CT, LLC

New Owner After Registration #1
16
LOUISVILLE, KY

Legal Representation

Attorney
Amy B. Berge

USPTO Deadlines

Next Deadline
946 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20220802)
Due Date
August 02, 2028
Grace Period Ends
February 02, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

27 events
Date Code Type Description Documents
Dec 8, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 8, 2025 EWOR I TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED Loading...
Dec 8, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 8, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 8, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Dec 8, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Sep 3, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Aug 2, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Aug 2, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 17, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 17, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 27, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 14, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 12, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 12, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 12, 2022 ALIE A ASSIGNED TO LIE Loading...
Apr 7, 2022 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Mar 24, 2022 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Mar 24, 2022 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Mar 24, 2022 CNSL R SUSPENSION LETTER WRITTEN Loading...
Mar 24, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 24, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 24, 2022 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Mar 24, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 22, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 13, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 5, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Cell therapy pharmaceutical preparations; pharmaceutical immunotherapy preparations for use in cancer treatment; T-cell receptors in the nature of pharmaceutical preparations for use in cancer treatment; pharmaceutical immunotherapy preparations comprising engineered T-cell receptors for use in cancer treatment; pharmaceutical immunotherapy preparations comprising genes encoding engineered T-cell receptors for use in cancer treatment
Class 044
Cell therapy medical treatment services; medical immunotherapy services; medical treatment and immune-therapy comprising harvesting a patient's white blood cells, combining white blood cells with an engineered T-cell receptor therapeutic, transducing the white blood cells with the gene encoding the engineered T-cell receptor and infusion of the transduced white blood cells back into the patient

Classification

International Classes
005 044